Related Experiment Video
Updated: Jun 26, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
CLP induces apoptosis in human leukemia K562 cells through Ca(2+) regulating extracellular-related protein kinase ERK
1Department of Microbiology, College of Life Science, Nankai University, Tianjin, China.
Abstract:
The cyclic lipopeptide (CLP) has been known to inhibit proliferation and induce apoptosis in cancer cells. However, the molecular mechanisms involved in CLP-induced apoptosis are still uncharacterized in human leukemic K562 cells. The current study investigated the molecular mechanism of action of CLP, purified from Bacillus natto T-2. CLP-induced a sustained increase in concentration of intracellular Ca(2+). This increase in [Ca(2+)]i was associated with CLP-induced cell apoptosis and ERK phosphorylation. CLP-induced cell apoptosis was reversed by PD98059 (an inhibitor of ERK), but not by SB203580 (an inhibitor of p38) and SP200125 (an inhibitor of JNK), suggesting that the action of CLP on K562 cells was via ERK, but not via p38 and JNK. On the other hand, pretreatment with Bapta-AM, a well-known calcium chelator, partially blocked CLP-induced apoptosis, indicating that the elevation of [Ca(2+)]i may play an important role in the apoptosis. Collectively, in K562 cells, CLP-induced an increase in [Ca(2+)]i which evoked ERK phosphorylation. This ERK phosphorylation subsequently activated Bax, cytochrome c and caspase-3 leading to apoptosis.
Insights
Bacillus natto T-2 cyclic lipopeptide (CLP) triggers apoptosis in K562 leukemia cells by increasing intracellular calcium and activating ERK signaling. This pathway ultimately leads to programmed cell death.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Oncology
Background:
- Cyclic lipopeptides (CLPs) are known to induce apoptosis in cancer cells.
- The precise molecular mechanisms of CLP-induced apoptosis in human leukemic K562 cells remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying CLP-induced apoptosis in K562 cells.
- To investigate the role of intracellular calcium and specific signaling pathways in CLP's apoptotic effects.
Main Methods:
- Purification of CLP from Bacillus natto T-2.
- Measurement of intracellular calcium ([Ca2+]i) levels.
- Assessment of apoptosis and Western blotting for ERK, p38, and JNK phosphorylation.
- Inhibition studies using PD98059 (ERK inhibitor), SB203580 (p38 inhibitor), SP200125 (JNK inhibitor), and Bapta-AM (calcium chelator).
Main Results:
- CLP treatment led to a sustained increase in intracellular calcium ([Ca2+]i).
- CLP induced K562 cell apoptosis and ERK phosphorylation.
- Apoptosis was reversed by an ERK inhibitor (PD98059) but not by p38 or JNK inhibitors.
- Calcium chelation partially blocked CLP-induced apoptosis.
- CLP-induced apoptosis involved the activation of Bax, cytochrome c, and caspase-3.
Conclusions:
- CLP induces apoptosis in K562 cells via a mechanism involving increased intracellular calcium and subsequent ERK pathway activation.
- The findings highlight the critical role of the calcium-ERK signaling axis in CLP-mediated apoptosis of human leukemia cells.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
Inhibition of Cdk Activity
Inhibition of CDK Activity
Caspases